NRXN1 and depressive symptom measurement: NRXN1 and its interacting genes are compelling candidates for suicide risk, as they are associated with a broad spectrum of neurological and psychiatric disorders (autism, schizophrenia, anxiety, depression, bipolar disorder, and attention deficit hyperactive disorder) [17, 19, 25, 57–59].